In the exciting new field of Radiomics, TexRAD uncovers biomarkers in medical images that are typically invisible to the naked eye.
TexRAD’s sophisticated patent-protected algorithm extracts and quantifies texture features in pre-existing medical images. These texture features have been successfully used to demonstrate diagnostic, prognostic and predictive intelligence in scientific research with particular significance in oncology. TexRAD has featured in over 100 academic publications, won numerous awards and is currently used in over 50 prestigious institutions worldwide.
TexRAD was originally invented by medical researchers from the Brighton and Sussex Medical School who aspired to create innovative and cost-effective medical imaging software to revolutionise management of diseases such as cancer. These scientists developed TexRAD in collaboration with radiologists and healthcare IT specialists to ensure confidence and optimal benefits in routine use. Building on the experience and success of TexRAD in research, we have recently launched TexRAD Lung, a software tool for the analysis of lung cancer which is CE marked for clinical use in the EU.
TexRAD Research, explore texture biomarkers for
research into diseases like cancer and more.
TexRAD Lung, explore texture biomarkers in lung cancer.